What FDA Approvals Really Tell Us About the State of Biopharmaceutical Innovation The FDA approved 37 novel medicines in 2022, a figure that sits modestly above the historical average. On the surface, it is an encouraging statistic. Beneath the headline, however, it tells a much more interesting story. Given the disruption caused by the COVID-19 pandemic, this level of productivity was far from inevitable. Clinical trial recruitment slowed dramatically during 2020 and 2021. H
